![]() § 1367, as the claimsĪrise out of the same “common nucleus of operative facts” as Plaintiff’s claim under the SecuritiesĨ. Interference with prospective business expectancy pursuant to 28 U.S.C. This Court has supplemental jurisdiction over Plaintiff’s state law claim for tortious §ġ331 because Plaintiff is asserting a claim under the Securities Exchange Act of 1934.ħ. This Court has subject matter jurisdiction over this case pursuant to 28 U.S.C. Defendant Accretive Capital LLC d/b/a Benzinga owns and operates a financialīenzinga is headquartered in Detroit, Michigan at One Campus Martius, SuiteĦ. Publisher of the Capybara Research Report.Ĭase 1:23-cv-11050 Document 1 Filed 12/20/23 of 19ĥ. Appelboom is the owner and operator of Capybara Research and the author and Defendant Igor Appelboom is an individual who resides in the country of Brazil atĪv Antonio Gil Veloso 2232, Es, Vila Velha, Brazil 29101-738.Ĥ. Defendant Capybara Research is a short selling research firm with an unknownģ. is a Delaware corporation with its principal place ofīusiness and headquarters located at 1070 Terra Bella Avenue, Mountain View, California 94043.Ģ. (“Benzinga,” together with the Capybara Defendants, “Defendants”).ġ. Research (“Capybara Research” or “Capybara”), Igor Appelboom (“Appelboom,” together withĬapybara Research, the “Capybara Defendants”) and Accretive Capital LLC d/b/a Benzinga Undersigned counsel, respectfully states as follows for its Complaint against Defendants Capybara (“KSCP,” “Knightscope” or “Plaintiff”), by and through their
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |